| 17.51 0.22 (1.27%) | 10-24 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 20.81 | 1-year : | 24.31 |
| Resists | First : | 17.81 | Second : | 20.81 |
| Pivot price | 17.31 |
|||
| Supports | First : | 16.7 | Second : | 16.01 |
| MAs | MA(5) : | 17.41 |
MA(20) : | 17.2  |
| MA(100) : | 15.19 |
MA(250) : | 14.8 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 74.9 |
D(3) : | 76.6 |
| RSI | RSI(14): 58 |
|||
| 52-week | High : | 21.05 | Low : | 10.18 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ ALHC ] has closed below upper band by 25.3%. Bollinger Bands are 60.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 17.62 - 17.71 | 17.71 - 17.79 |
| Low: | 17 - 17.09 | 17.09 - 17.18 |
| Close: | 17.36 - 17.51 | 17.51 - 17.65 |
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada. It also coordinates and provides covered health care services, including professional, institutional, and ancillary services to members enrolled in certain benefit plans of unaffiliated Medicare Advantage Health Maintenance Organizations. The company was founded in 2013 and is based in Orange, California.
Thu, 23 Oct 2025
Alignment Healthcare (ALHC): Evaluating Valuation After National Recognition and Bilingual Care Expansion - Yahoo Finance
Wed, 22 Oct 2025
How Alignment Healthcare Inc. (ALHC) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Wed, 22 Oct 2025
Alignment Health (NASDAQ: ALHC) named 2026 Best Medicare Advantage insurer in 5 states - Stock Titan
Tue, 21 Oct 2025
Alignment Health (ALHC) partners with Suvida to expand bilingual care in Phoenix & Tucson - Stock Titan
Tue, 21 Oct 2025
Alignment Healthcare, Inc. (ALHC) Stock Analysis: Navigating Growth with a 49% Revenue Surge - DirectorsTalk Interviews
Tue, 14 Oct 2025
Goldman Sachs Initiates Coverage of Alignment Healthcare (ALHC) with Buy Recommendation - Nasdaq
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Plans
|
|
| Shares Out | 198 (M) |
| Shares Float | 153 (M) |
| Held by Insiders | 3.7 (%) |
| Held by Institutions | 93.4 (%) |
| Shares Short | 14,330 (K) |
| Shares Short P.Month | 12,050 (K) |
| EPS | -0.28 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.7 |
| Profit Margin | -1.6 % |
| Operating Margin | 2.2 % |
| Return on Assets (ttm) | -1.5 % |
| Return on Equity (ttm) | -38.6 % |
| Qtrly Rev. Growth | 49 % |
| Gross Profit (p.s.) | 2.04 |
| Sales Per Share | 16.86 |
| EBITDA (p.s.) | 0.03 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 63 (M) |
| Levered Free Cash Flow | 44 (M) |
| PE Ratio | -64.86 |
| PEG Ratio | 0 |
| Price to Book value | 24.66 |
| Price to Sales | 1.03 |
| Price to Cash Flow | 54.83 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|